Get started
PURE BiosciencePURE BiosciencePURE Bioscience

PURE Bioscience

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Seasonals

PURE chart


Full chart

PURE upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪6.87 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.0277 USD
Net income (FY)
‪−3.35 M‬ USD
Revenue (FY)
‪1.96 M‬ USD
Shares float
‪65.71 M‬
Beta (1Y)
−0.21

Employees


Employees (FY)
12
Change (1Y)
0
Revenue / Employee (1Y)
‪163.58 K‬ USD
Net income / Employee (1Y)
‪−279.17 K‬ USD

About PURE Bioscience


Sector
Process Industries
Industry
Chemicals: Major Diversified
CEO
Robert F. Bartlett
Website
purebio.com
Headquarters
El Cajon
Founded
1992
FIGI
BBG000BVNM59
PURE Bioscience, Inc. engages in the discovery, development, and commercialization of proprietary antimicrobial products for pathogen and hygienic control. It offers silver dihydrogen citrate-based disinfecting and sanitizing products. The company was founded by Michael L. Krall on August 24, 1992 and is headquartered in El Cajon, CA.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

PURE news



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Check out other big names from the same industry as PURE.

Frequently Asked Questions


The current price of PURE is 0.0620 USD — it has decreased by −0.81% in the past 24 hours. Watch PURE Bioscience stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange PURE Bioscience stocks are traded under the ticker PURE.
PURE stock has fallen by −10.89% compared to the previous week, the month change is a 27.39% rise, over the last year PURE Bioscience has showed a −7.40% decrease.
PURE reached its all-time high on Nov 14, 2007 with the price of 558.0800 USD, and its all-time low was 0.0450 USD and was reached on Mar 10, 2025. View more price dynamics on PURE chart.
See other stocks reaching their highest and lowest prices.
PURE stock is 11.15% volatile and has beta coefficient of −0.21. Track PURE Bioscience stock price on the chart and check out the list of the most volatile stocks — is PURE Bioscience there?
Today PURE Bioscience has the market capitalization of ‪6.87 M‬, it has decreased by −10.29% over the last week.
Yes, you can track PURE Bioscience financials in yearly and quarterly reports right on TradingView.
PURE Bioscience is going to release the next earnings report on Jun 12, 2025. Keep track of upcoming events with our Earnings Calendar.
PURE net income for the last quarter is ‪−798.00 K‬ USD, while the quarter before that showed ‪−689.00 K‬ USD of net income which accounts for −15.82% change. Track more PURE Bioscience financial stats to get the full picture.
No, PURE doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Apr 17, 2025, the company has 12 employees. See our rating of the largest employees — is PURE Bioscience on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. PURE Bioscience EBITDA is ‪−2.73 M‬ USD, and current EBITDA margin is −151.96%. See more stats in PURE Bioscience financial statements.
Like other stocks, PURE shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade PURE Bioscience stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So PURE Bioscience technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating PURE Bioscience stock shows the sell signal. See more of PURE Bioscience technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.